Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

NCT00017186 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Malignant Mesothelioma

Interventions

DRUG: epirubicin hydrochloride
DRUG: gemcitabine hydrochloride

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]